Zealand Pharma A/s Stock
Zealand Pharma A/s Stock
We can see a decrease in the price for Zealand Pharma A/s. Compared to yesterday it has lost -€1.100 (-1.650%).
So far the community has only identified positive things for Zealand Pharma A/s stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Zealand Pharma A/s in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Zealand Pharma A/s vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Zealand Pharma A/s | -1.650% | -2.493% | -3.371% | -37.441% | -31.195% | 144.126% | - |
| Saniona AB | 3.030% | 11.665% | 48.048% | 242.957% | 182.521% | 654.111% | -2.376% |
| Actinium Pharmaceuticals Inc. | 3.820% | 4.739% | 16.334% | 10.708% | 11.381% | -87.590% | -86.784% |
| NanoViricides Inc. | -3.670% | 4.808% | -12.097% | -21.583% | -27.333% | -9.693% | -61.888% |
News
Why Rocket Lab Stock Keeps Going Up
Rocket Lab (NASDAQ: RKLB) stock rocketed to a 10th straight day of gains Friday, surging 5.7% through 11:15 a.m. ET after announcing the New Zealand-based space company announced yet another big
Cantor Boosts Rocket Lab Target to Street-High $35
Aerospace and defense corporation Rocket Lab USA (NASDAQ: RKLB) recently received a significant analyst boost when Cantor Fitzgerald increased its target price for the space company to a
